SEPN
Price:
$35.95
Market Cap:
$1.62B
Septerna, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to the identification and advancement of orally administered, small molecule therapies that modulate G protein-coupled receptors (GPCRs). The company's pipeline is designed to address a spectrum of conditions within endocrinology, immunology and inflammation, and metabolic disorders. Among its key programs, Septerna is developing SEP-786, an oral small molecule serving as a PTH1R agonist for individuals suffering from hypoparathyroidism. Another candidate, SEP-631, is an oral small molecule MRGPRX2 NAM aimed at treating chronic spontaneous urticaria and other mast cell-related ailments. Furthermore, its T...[Read more]
Industry
Biotechnology
IPO Date
2024-10-25
Stock Exchange
NASDAQ
Ticker
SEPN
According to Septerna, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.57B. This represents a change of 109.30% compared to the average of 751.04M of the last 4 quarters.
The mean historical Enterprise Value of Septerna, Inc. over the last ten years is 521.81M. The current 1.57B Enterprise Value has changed 30.03% with respect to the historical average. Over the past ten years (40 quarters), SEPN's Enterprise Value was at its highest in in the December 2025 quarter at 1.14B. The Enterprise Value was at its lowest in in the September 2023 quarter at 0.
Average
521.81M
Median
490.15M
Minimum
-29897000.00
Maximum
1.14B
Discovering the peaks and valleys of Septerna, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 87.23%
Maximum Annual Enterprise Value = 1.14B
Minimum Annual Increase = -1241.56%
Minimum Annual Enterprise Value = -29897000.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.14B | 77.91% |
| 2024 | 639.00M | 87.23% |
| 2023 | 341.29M | -1241.56% |
The current Enterprise Value of Septerna, Inc. (SEPN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
705.71M
5-year avg
521.81M
10-year avg
521.81M
Septerna, Inc.’s Enterprise Value is greater than Bicara Therapeutics Inc. Common Stock (866.15M), less than Tango Therapeutics, Inc. (3.73B), greater than Fortrea Holdings Inc. (1.49B), greater than Prime Medicine, Inc. (551.62M), greater than Kura Oncology, Inc. (788.60M), greater than EyePoint Pharmaceuticals, Inc. (1.03B), greater than ProKidney Corp. (1.15B), less than Maravai LifeSciences Holdings, Inc. (2.49B), greater than Nurix Therapeutics, Inc. (1.46B), greater than Arbutus Biopharma Corporation (818.44M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 866.15M | $1.19B | |
| 3.73B | $3.85B | |
| 1.49B | $1.56B | |
| 551.62M | $501.21M | |
| 788.60M | $803.41M | |
| 1.03B | $1.09B | |
| 1.15B | $551.46M | |
| 2.49B | $1.38B | |
| 1.46B | $1.47B | |
| 818.44M | $841.51M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Septerna, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Septerna, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Septerna, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Septerna, Inc. (SEPN)?
What is the 3-year average Enterprise Value for Septerna, Inc. (SEPN)?
What is the 5-year average Enterprise Value for Septerna, Inc. (SEPN)?
How does the current Enterprise Value for Septerna, Inc. (SEPN) compare to its historical average?